The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome
暂无分享,去创建一个
B. Iung | M. Chauvet | A. Vahanian | P. Nataf | E. Brochet | D. Himbert | M. Urena | S. Provenchère | W. Ghodbane | C. Bouleti | P. Ou | G. Franchineau | B. Alos
[1] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[2] M. Mack,et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.
[3] B. Iung,et al. Long-term outcome after transcatheter aortic valve implantation , 2015, Heart.
[4] E. Tuzcu,et al. Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). , 2015, JACC. Cardiovascular interventions.
[5] M. Mack,et al. Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy , 2014, Circulation.
[6] M. Seeberger,et al. Troponin T and B-Type Natriuretic Peptide After On-Pump Cardiac Surgery: Prognostic Impact on 12-Month Mortality and Major Cardiac Events After Adjustment for Postoperative Complications , 2014, Circulation.
[7] P. Jüni,et al. Long-term outcome of elderly patients with severe aortic stenosis as a function of treatment modality , 2014, Heart.
[8] Nancy M Albert,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.
[9] Thoralf M Sundt,et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.
[10] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[11] Pascal Leprince,et al. Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score , 2014, Heart.
[12] R. Guyton,et al. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement. , 2013, The Journal of thoracic and cardiovascular surgery.
[13] M. de Bonis,et al. [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. , 2013, Giornale italiano di cardiologia.
[14] Anson Cheung,et al. 5-year outcome after transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.
[15] S. Windecker,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.
[16] Scott Lim,et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.
[17] R. Lange,et al. One-Year Outcomes of Cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: The European Registry of Transcatheter Aortic Valve Implantation Using the Edwards SAPIEN Valve , 2011, Circulation.
[18] B. Iung,et al. Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[19] B. Carabello. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.
[20] Fabian Nietlispach,et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. , 2010, Journal of the American College of Cardiology.
[21] Y. Castier,et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. , 2008, European heart journal.
[22] B. Carabello. Aortic stenosis: two steps forward, one step back. , 2007, Circulation.
[23] O. Alfieri,et al. Guidelines on the management of valvular heart disease. , 2007, European heart journal.
[24] Philippe Ravaud,et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? , 2005, European heart journal.
[25] Assaf Bash,et al. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description , 2002, Circulation.
[26] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[27] Jean-Louis Vanoverschelde,et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, European heart journal.
[28] D. Shavelle,et al. Current results of balloon aortic valvuloplasty in high-risk patients. , 2007, The Journal of invasive cardiology.